Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 24:13:85-96.
doi: 10.2147/IJNRD.S198222. eCollection 2020.

Evaluating Nephrocheck® as a Predictive Tool for Acute Kidney Injury

Federico Nalesso  1 , Leda Cattarin  1 , Laura Gobbi  1 , Antonio Fragasso  1 , Francesco Garzotto  2 , Lorenzo Arcangelo Calò  1
Affiliations
Review

Evaluating Nephrocheck® as a Predictive Tool for Acute Kidney Injury

Federico Nalesso et al. Int J Nephrol Renovasc Dis. .

Abstract

Acute kidney injury (AKI) is a common complication in critically ill patients in the intensive settings with increased risks of short- and long-term complications and mortality. AKI is also associated with an increased length of stay in intensive care units (ICU) and worse kidney function recovery at hospital discharge. The management of AKI is one of the major challenges for nephrologists and intensivists overall for its early diagnosis. The current KDIGO criteria used to define AKI include the serum creatinine and urinary output that are neither sensitive nor specific markers of kidney function, since they can be altered only after hours from the kidney injury. In order to allow an early AKI detection, in the last years, several studies focused on the identification of new biomarkers. Among all these markers, urinary insulin-like growth factor-binding protein (IGFBP-7) and tissue inhibitor of metalloproteinase (TIMP-2) have been proven as the best-performing and have been proposed as a predictive tool for the AKI detection in the critical settings in order to perform an early diagnosis. Patients undergoing major surgery, cardiac surgery, those with hemodynamic instability or those with sepsis are believed to be the top priority patient populations for the biomarker test. In this view, the urinary [TIMP-2] x [IGFBP-7] becomes an important tool for the early detection of patients at high risk for AKI and its integration with the local ICU experience has to provide a multidisciplinary management of AKI with the institution of a rapid response team in order to assess patients and customize AKI management.

Keywords: IGFBP-7; KIM-1; L-FABP; NGAL; TIMP-2; interleukin-18.

PubMed Disclaimer

Conflict of interest statement

Financial support: no grants or funding have been received for this study. The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP-7) (Created with BioRender).
Figure 2
Figure 2
The AKI assessment (Created with BioRender).
See this image and copyright information in PMC

References

    1. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients. a multinational, multicenter study. JAMA. 2005;294(7):813–818. doi:10.1001/jama.294.7.813 - DOI - PubMed
    1. Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: improving Global Outcomes (KDIGO) acute kidney injury work group. KDIGO Clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:19–36.
    1. Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411–1423. doi:10.1007/s00134-015-3934-7 - DOI - PubMed
    1. Bellomo R, Ronco C, Kellum JA, Mehta RL; Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care. 2004;8:R204–12. doi:10.1186/cc2872 - DOI - PMC - PubMed
    1. Haase M, Kellum JA, Ronco C. Subclinical AKI–an emerging syndrome with important consequences. Nat Rev Nephrol. 2012;8(12):735–739. doi:10.1038/nrneph.2012.197 - DOI - PubMed